blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1974727

EP1974727 - THERAPEUTIC AGENT FOR ACUTE CEREBRAL INFARCT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.11.2010
Database last updated on 21.08.2024
Most recent event   Tooltip26.11.2010Application deemed to be withdrawnpublished on 29.12.2010  [2010/52]
Applicant(s)For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
[2008/40]
Inventor(s)01 / KAJITANI, Hitoshi
ONO PHARMACEUTICAL CO., LTD. 1-5, Doshomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 5418526 / JP
02 / FUNAKOSHI, Yosuke
ONO PHARMACEUTICAL CO., LTD. 1-5, Doshomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 5418526 / JP
03 / KITAO, Dai
ONO PHARMACEUTICAL CO., LTD. 1-5, Doshomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 5418526 / JP
 [2008/40]
Representative(s)Schön, Christoph, et al
Kroher-Strobel
Rechts- und Patentanwälte PartmbB
Bavariaring 20
80336 München / DE
[N/P]
Former [2009/41]Schön, Christoph, et al
Kroher.Strobel Rechts- und Patentanwälte Bavariaring 20
80336 München / DE
Former [2008/40]Henkel, Feiler & Hänzel
Patentanwälte Maximiliansplatz 21
80333 München / DE
Application number, filing date06842989.321.12.2006
[2008/40]
WO2006JP325481
Priority number, dateJP2005036915422.12.2005         Original published format: JP 2005369154
[2008/40]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007072902
Date:28.06.2007
Language:JA
[2007/26]
Type: A1 Application with search report 
No.:EP1974727
Date:01.10.2008
Language:EN
[2008/40]
Search report(s)International search report - published on:JP28.06.2007
(Supplementary) European search report - dispatched on:EP09.11.2009
ClassificationIPC:A61K31/20, A61P9/10, A61P25/28
[2008/40]
CPC:
A61K31/20 (EP,US); A61P25/00 (EP); A61P25/28 (EP);
A61P9/00 (EP); A61P9/10 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/40]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:THERAPEUTISCHES MITTEL GEGEN AKUTEN ZEREBRALINFARKT[2008/40]
English:THERAPEUTIC AGENT FOR ACUTE CEREBRAL INFARCT[2008/40]
French:AGENT THERAPEUTIQUE POUR INFARCTUS CEREBRAL AIGU[2008/40]
Entry into regional phase21.07.2008Translation filed 
21.07.2008National basic fee paid 
21.07.2008Search fee paid 
21.07.2008Designation fee(s) paid 
21.07.2008Examination fee paid 
Examination procedure21.07.2008Amendment by applicant (claims and/or description)
21.07.2008Examination requested  [2008/40]
23.02.2010Despatch of a communication from the examining division (Time limit: M04)
06.07.2010Application deemed to be withdrawn, date of legal effect  [2010/52]
11.08.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/52]
Fees paidRenewal fee
29.12.2008Renewal fee patent year 03
28.12.2009Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]  - SORBERA L A ET AL, "Arundic acid - Astrocyte-modulating agent treatment of stroke treatment of neurodegeneration", DRUGS OF THE FUTURE, (200405), vol. 29, no. 5, ISSN 0377-8282, pages 441 - 448, XP002552188 [X] 1-15 * abstract * * page 446, column 1, paragraph 3 * * page 446, column 1, paragraph 5 - column 2, paragraph 1 * * page 446, column 2, paragraph 5 - page 447, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1358/dof.2004.029.05.810151
 [XY]  - ASANO T ET AL, "Arundic acid (ONO-2506) ameliorates delayed ischemic brain damage by preventing astrocytic overproduction of S100B.", CURRENT DRUG TARGETS. CNS AND NEUROLOGICAL DISORDERS APR 2005, (200504), vol. 4, no. 2, ISSN 1568-007X, pages 127 - 142, XP009124642 [XY] 1-15 * abstract * * page 133, column 1, paragraph 1 - page 134, column 2, paragraph 2 * * page 136, column 2, paragraph 2 * * page 138, column 2, paragraph 1 *

DOI:   http://dx.doi.org/10.2174/1568007053544084
 [XY]  - ASANO T ET AL, "Functional modulation of astrocytes by a novel agent ONO-2506 mitigates delayed infarct expansion with a wide therapeutic time window, inducing prompt neurological recovery through reduction of the extracellular level of glutamate", INTERNATIONAL CONGRESS SERIES, EXCERPTA MEDICA, AMSTERDAM, NL, (20030101), vol. 1252, ISSN 0531-5131, pages 147 - 151, XP003007242 [XY] 1-15 * abstract; page 150, column 2 *

DOI:   http://dx.doi.org/10.1016/S0531-5131(03)00028-1
 [XY]  - TATEISHI NARITO ET AL, "Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits.", JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM : OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY OF CEREBRAL BLOOD FLOW AND METABOLISM JUN 2002, (200206), vol. 22, no. 6, ISSN 0271-678X, pages 723 - 734, XP002552189 [XY] 1-15 * abstract * * page 727, column 1, paragraph 2 *
 [PX]  - FOR THE ARUNDIC ACID (ONO-2506) STROKE STUDY GROUP ET AL, "Safety and tolerability of arundic acid in acute ischemic stroke", JOURNAL OF NEUROLOGICAL SCIENCES, ELSEVIER SCIENTIFIC PUBLISHING CO, AMSTERDAM, NL, vol. 251, no. 1-2, ISSN 0022-510X, (20061221), pages 50 - 56, (20061221), XP025190710 [PX] 1-15 * abstract * * tables 2,4-6 *

DOI:   http://dx.doi.org/10.1016/j.jns.2006.09.001
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.